NRP1 and systemic sclerosis: In the former, serum levels of soluble NRP1 (sNRP1) were found to be significantly decreased in SSc patients with respect to healthy controls and to progressively decline within the SSc group, reaching the lowest values in those patients with the active and late NVC patterns [118].